🇺🇸 FDA
Patent

US 6610302

Anti-tumor activity of Ea-2 and Ea-4-peptide of pro-IGF-I

expired A61KA61K31/711A61K38/30

Quick answer

US patent 6610302 (Anti-tumor activity of Ea-2 and Ea-4-peptide of pro-IGF-I) held by UNIVERSITY OF CONNECTICUT expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/711, A61K38/30, A61P, A61P35/00